A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The participants will be treated with either zasocitinib, or placebo. Participants will be in the study for up to 60 weeks.
Epistemonikos ID: 2888387fb7d35e1b92605767ac887c5e88f3a8a3
First added on: Dec 01, 2024